STAT News Highlights Supplement Trends, Medicare Weight Loss, and Utah DUI Law

STAT News's free weekday newsletter, 'Morning Rounds,' covers a range of health topics, including how supplement use has evolved over decades. Recent reports also feature discussions on Medicare-funded weight loss initiatives and Utah's adjusted drunk driving limit, delivering daily updates on health and medicine.

By Fainaron·Jun 16, 2026 (an hour ago)·1 views

STAT News Highlights Supplement Trends, Medicare Weight Loss, and Utah DUI Law

STAT News offers a free daily newsletter, "Morning Rounds," providing updates on health and medicine every weekday. This publication has recently featured several key health topics, including an examination of how supplement use has changed over decades.

The newsletter's coverage extends to health policy discussions, such as Medicare-funded weight loss programs. "Morning Rounds" has also reported on legislative changes, specifically Utah's adjustment to its drunk driving limit.

In addition to these core health and medicine updates, the daily digest includes broader discussions. One recent example highlighted a perspective from Defector regarding commercial hydration breaks in soccer.

(Source: STAT News)

#supplements #health policy #weight loss #drunk driving #utah #stat news #morning rounds

Source attribution: This article was AI-curated and rewritten by Fainaron from a piece originally published by STAT News. Read the original at STAT News →

More like this

New HIV Drug Lenacapavir Set for Mass Rollout in Southern Africa

Health

11 minutes ago

New HIV Drug Lenacapavir Set for Mass Rollout in Southern Africa

A new preventive treatment for HIV, Lenacapavir, is slated for a large-scale rollout across several Southern African nations. Administered just twice a year, the drug has demonstrated high efficacy, offering more than 99% protection against the virus. Following years of research and clinical trials, the treatment has received approval and is now set to be deployed in a region significantly impacted by HIV/AIDS, including South Africa, Zambia, and Mozambique.

Verge Genomics Utilizes Failed ALS Clinical Trial Data for New AI Benchmark

Verge Genomics, a company focused on developing treatments for neurodegenerative diseases, plans to convert data from its recently failed Phase 1b clinical trial for an ALS drug into a new artificial intelligence (AI) benchmarking dataset. Co-founded by Alice Zhang, the company aims to extract valuable insights from the trial's challenges, particularly the high patient dropout rate due to drug intolerance. This initiative underscores Verge Genomics' commitment to sharing learnings from unsuccessful trials to benefit the broader field of neurology and drug development.

Beekeeper's Naturals Recalls Saline Nasal Spray Due to Possible Mold Contamination

Beekeeper's Naturals has initiated a voluntary recall of its Saline Nasal Spray. The company's decision follows product testing that indicated possible mold contamination. The nasal spray, which was available for purchase on Amazon, is being recalled as a precautionary measure.

U.S. Faces Challenges in Current Ebola Outbreak Response

The United States, historically recognized as a pioneer in the worldwide fight against infectious diseases, is reportedly encountering difficulties in its response to a current deadly Ebola outbreak. The nation is described as 'playing catch-up' with the health crisis, indicating a departure from its past leadership role in global health initiatives.

The Hill

Back to Homepage

STAT News Highlights Supplement Trends, Medicare Weight Loss, and Utah DUI Law

More like this

New HIV Drug Lenacapavir Set for Mass Rollout in Southern Africa

Verge Genomics Utilizes Failed ALS Clinical Trial Data for New AI Benchmark

Beekeeper's Naturals Recalls Saline Nasal Spray Due to Possible Mold Contamination

U.S. Faces Challenges in Current Ebola Outbreak Response

Fainaron — live counters